Loading asset research
Q3 2026 earnings · Oct 27
GeneDx Holdings Corp. Class A Common Stock
WGSNasdaq · USD · StocksQuote as of · Exchange session not verified$85.24
+1.52%
Today
WGS
Loading 1D prices…
Market cap
$2.5B
Volume
331.6K
52w high
$170.8752w low
$32.21Company profile
GeneDx Holdings Corp. Class A Common Stock
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Sector
Health Care
Industry
Services-Health Services
Exchange
Nasdaq
Display currency
USD
Location
Stamford, CT, United States
Employees
1.3K
Fiscal year end
1231
CIK
1818331
Session & valuation
Open$85.17
Previous close$83.96
Day high$87.62
Day low$84.36
30-day avg. volume667.7K
Outstanding shares29.8M
Diluted EPS-$0.73
Latest annual period
P/E (trailing)-116.76
P/E (forward)72.95
Price / book10.41
Beta2.01
Dividend yield—
Deterministic peer set
Companies with SEC SIC 8000
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PRVAPrivia Health Group Inc. Common Stock | $2.6B | $2.1B | +1.08% | $0.18 | +0.25% | Buy |
| PIIIP3 Health Partners Inc. Class A Common Stock | $1.7B | $1.5B | -10.14% | -$45.26 | +0.84% | Buy |
| INNVInnovAge Holding Corp. Common Stock | $1.5B | $989.7M | -0.26% | -$0.02 | +1.23% | Hold |
| PNTGThe Pennant Group Inc. Common Stock | $1.4B | $947.7M | +3.12% | $0.84 | -0.20% | Buy |
| LFSTLifeStance Health Group Inc. Common Stock | $5B | $1.4B | +0.68% | $0.02 | -0.23% | Buy |